<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: We have recently demonstrated that <z:chebi fb="5" ids="18154">polysaccharides</z:chebi> from fruiting body extract (FBE) or mycelia extract (ME) of the edible mushroom Pleurotus pulmonarius exert antiproliferative effects in intestinal cells and an anti-inflammatory effect in a <z:chebi fb="0" ids="34674">dextran sulfate</z:chebi> <z:chebi fb="199" ids="26708">sodium</z:chebi> (DSS) mouse model of <z:hpo ids='HP_0100282'>acute colitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to assess the role of fungal FBE and ME in colon <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: In vitro, human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells were treated with FBE and ME and analyzed for <z:mp ids='MP_0001845'>inflammation</z:mp> response, for markers of <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, and for cell-cycle progression </plain></SENT>
<SENT sid="3" pm="."><plain>In vivo, FBE and ME were tested in a mouse model of <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> induced by cyclic treatments with DSS and azoxymethane </plain></SENT>
<SENT sid="4" pm="."><plain>Treated mice were fed a daily diet containing 2 or 20 mg FBE or ME per mouse for 80 days </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: In vitro, FBE and ME induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in a dose-responsive manner and modulated the expression of Bcl-2, Bax, and <z:chebi fb="1" ids="18070">cytochrome c</z:chebi>, and blocked <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF)-α-induced inhibitor of nuclear factor (NF) (Iκ)-Bα degradation and NF-κB nuclear translocation </plain></SENT>
<SENT sid="6" pm="."><plain>In vivo, dietary administration of FBE and ME significantly reduced the formation of <z:mpath ids='MPATH_557'>aberrant crypt foci</z:mpath>, which precedes <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, and of microadenomas </plain></SENT>
<SENT sid="7" pm="."><plain>The treatments significantly lowered the expression of proliferating cell nuclear antigen and increased the number of cells undergoing <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the colon </plain></SENT>
<SENT sid="8" pm="."><plain>Additionally, FBE and ME inhibited the expression of the proinflammatory cytokine TNF-α in colonic tissue </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: We conclude that P. pulmonarius FBE and ME inhibit <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated colon <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> induced in mice through the modulation of cell proliferation, induction of <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, and inhibition of <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
</text></document>